Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 01:00 ET | Source: PolTREG S.A.

PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independence

PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 yearsA proportion of patients remained insulin-independent for up to 24 monthsPTG-007 ready to enter pivotal studyData...
March 11, 2024 02:00 ET | Source: PolTREG S.A.

PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland

Gdańsk, Poland – 11 March 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it...